CAS: 23785-21-9; Ethyl 1H-Imidazole-4-Carboxylate

相似化合物

1072-84-0 3034-50-2 32673-41-9

上下游产品

H-imidazole-4-carboxylic acid ethyl ester2-thioxo-2,3-dihydro-1H-imidazole-4-carboxylic acid ethyl ester ethanol carbon dioxideimidazole-4-carboxamide 1H-imidazole-4-carboxylic acid hydrazide ethyl 1-benzyl-1H-imidazole-5-carboxylic acid

5H,10H-二咪唑并[1,5-A:1,5-D] 吡嗪-5,10-二酮 以 乙醇 用作溶剂,化学反应 18.0H,以39%的收率获得咪唑-4-甲酸乙酯
参考文献:Yasuda,Naohiko; Nakamura,Asao; Tsuboi,Masamichi,Journal Of Heterocyclic Chemistry,1987,Vol. 24,P. 303-307
标题:Yasuda,Naohiko; Nakamura,Asao; Tsuboi,Masamichi,Journal Of Heterocyclic Chemistry,1987,Vol. 24,P. 303-307

专利信息

专利号:WO-2024041555-A1
优先权日:2022-08-24
标 题:Methods of manufacturing kinase inhibitors
发明人：LIANG XING; CAO HUA; CHENG XIN; QIN LUOHENG
权利人:INSILICO MEDICINE IP LTD
摘要:In one aspect, the disclosure provides methods of synthesizing TNIK and/or MAP4K4 kinases inhibitors for the treatment of disease. In one aspect, the disclosure provides intermediates used in the synthesis methods described herein.

专利号:US-2008200475-A1
优先权日:2005-03-28
标题:4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
权利人:PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: (I) wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2a , R x , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:CN-105693619-A
优先权日:2016-03-01
标题:A kind of method of inorganic salt composite catalyst catalytic synthesis 1H-imidazole-4-formic acid